Pantoro Gold has given back 21% over the past month and 10% on the week to AUD 1.985 — a drawdown that is almost entirely company-specific, not a sector story.
The peer gap makes that clear. Westgold Resources, Regis Resources, and Evolution Mining each fell roughly 1% on the week. Even the harder-hit names — BGD, CMM, and EMR — gave back 3–4%. Pantoro's weekly decline is two to three times worse than the worst of those. With gold prices not the culprit, the July 20 results report is where the market will look for an explanation.
Short sellers are not responsible for the damage — and that contrast matters. Borrow availability is extremely loose at 6,703%, meaning roughly 67 shares remain available for every one already lent out. That figure has more than doubled on the week, reflecting shorts actively closing rather than pressing. Short interest has fallen 8% over the past week and 25% over the past month, settling at just 1.6% of free float — a low reading that continues to ease. The ORTEX short score has drifted down to 31 from 33 ten days ago, reinforcing the picture of retreating rather than building bear conviction. With borrowing costs running at just 0.71% annually, there is no cost pressure driving that exit either — shorts are simply choosing to step away ahead of the event.
The institutional picture adds texture. Regal Partners trimmed its stake by 4.5 million shares as of late June, while UBS Asset Management cut by nearly 7 million shares reported July 1. Those are meaningful reductions from two of the top-four holders. Against that, Dimensional Fund Advisors added 2.3 million shares and American Century built a position of 1.8 million shares over the same period — smaller additions that partially offset the selling. The heaviest insider activity on record is now stale (the December 2025 Tulla Resources disposal and CEO sales from late 2025), so recent institutional flows are the more current signal of where conviction sits.
The historical earnings pattern offers little comfort for bulls. The most recent print — April 28 — resulted in a 14% one-day fall and a 17% decline over the following five days. That reaction, combined with a stock that has already shed a fifth of its value heading in, means the July 20 report is testing whether whatever drove that April damage has been resolved, or whether it is still unfolding.
See the live data behind this article on ORTEX.
Open PNR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
